ID

12754

Beschrijving

GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01518517

Link

https://clinicaltrials.gov/show/NCT01518517

Trefwoorden

  1. 21-12-15 21-12-15 -
Geüploaded op

21 december 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient from 1 to 55 years old (children and adolescents from 1 to 17 years/ adults from 18 to 55 years)
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
patients with 1st all relapse, which could be either isolated bone marrow relapse, or combined (medullary and extra-medullary) relapse, or extra-medullary isolated relapse; or lymphoblastic lymphoma (excepted burkitt lymphoma) or failure to all first line treatment (no complete remission obtained)
Beschrijving

ALL relapse first

Datatype

boolean

Alias
UMLS CUI [1,1]
C2367454
UMLS CUI [1,2]
C0205435
patient previously treated with free e.coli l-asparaginase form or pegylated one
Beschrijving

Therapy l-asparaginase (E.Coli)

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C3255308
performance status ≤ 2 (who score)
Beschrijving

WHO performance status scale

Datatype

boolean

Alias
UMLS CUI [1]
C1298650
patient informed and consent provided (the 2 parents need to consent when children are below 18)
Beschrijving

informed consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
all t(9;22) and/or bcr-abl positive (philadelphia chromosome positive)
Beschrijving

philadelphia chromosome positive

Datatype

boolean

Alias
UMLS CUI [1]
C0856536
patient with 2nd relapse and over
Beschrijving

Leukaemia recurrent second

Datatype

boolean

Alias
UMLS CUI [1,1]
C0920028
UMLS CUI [1,2]
C0205436
women of childbearing potential without effective contraception as well as pregnant or breast feeding women
Beschrijving

Lactating; Patient currently pregnant; Contraception status

Datatype

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
UMLS CUI [3]
C0420837
patient unable to receive treatments used in global chemotherapy protocols, due to general or visceral conditions such as:severe cardiac impairment (nyha grade 3 or 4 cardiomyopathy)/serum creatinine 2 x uln unless related to all /alt or ast 5 x uln unless related to all /pancreatitis history /other malignancy that all / severe infection, hiv positive, active hepatitis related to b or c virus infection / trisomy 21 / other serious conditions according to investigator's opinion
Beschrijving

chemotherapy limited Comorbidity

Datatype

boolean

Alias
UMLS CUI [1,1]
C3665472
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
known grade 4 allergic reaction to e.coli l-asparaginase (according nci-ctcae, version 3.0)
Beschrijving

allergy e.coli l-asparaginase

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C3255308
history of grade 3 transfusional incident
Beschrijving

Transfusion Grade three rank

Datatype

boolean

Alias
UMLS CUI [1,1]
C1879316
UMLS CUI [1,2]
C0450094
presence of specific anti-erythrocyte antibodies preventing from getting a compatible erythrocyte concentrate for the patient
Beschrijving

Antierythrocyte Antibody

Datatype

boolean

Alias
UMLS CUI [1]
C0236506
patient under concomitant treatment likely to cause hemolysis
Beschrijving

hemolysis; Concomitant Therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0019054
UMLS CUI [2]
C1707479
patient undergoing yellow fever vaccination
Beschrijving

yellow fever vaccination

Datatype

boolean

Alias
UMLS CUI [1]
C0199823
patient under phenytoin treatment
Beschrijving

phenytoin treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0747579
patient included in previous clinical study less than 6 weeks ago
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Acute Lymphoblastic Leukemia, in Relapse NCT01518517

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patient from 1 to 55 years old (children and adolescents from 1 to 17 years/ adults from 18 to 55 years)
boolean
C0001779 (UMLS CUI [1])
ALL relapse first
Item
patients with 1st all relapse, which could be either isolated bone marrow relapse, or combined (medullary and extra-medullary) relapse, or extra-medullary isolated relapse; or lymphoblastic lymphoma (excepted burkitt lymphoma) or failure to all first line treatment (no complete remission obtained)
boolean
C2367454 (UMLS CUI [1,1])
C0205435 (UMLS CUI [1,2])
Therapy l-asparaginase (E.Coli)
Item
patient previously treated with free e.coli l-asparaginase form or pegylated one
boolean
C0087111 (UMLS CUI [1,1])
C3255308 (UMLS CUI [1,2])
WHO performance status scale
Item
performance status ≤ 2 (who score)
boolean
C1298650 (UMLS CUI [1])
informed consent
Item
patient informed and consent provided (the 2 parents need to consent when children are below 18)
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
philadelphia chromosome positive
Item
all t(9;22) and/or bcr-abl positive (philadelphia chromosome positive)
boolean
C0856536 (UMLS CUI [1])
Leukaemia recurrent second
Item
patient with 2nd relapse and over
boolean
C0920028 (UMLS CUI [1,1])
C0205436 (UMLS CUI [1,2])
Lactating; Patient currently pregnant; Contraception status
Item
women of childbearing potential without effective contraception as well as pregnant or breast feeding women
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
C0420837 (UMLS CUI [3])
chemotherapy limited Comorbidity
Item
patient unable to receive treatments used in global chemotherapy protocols, due to general or visceral conditions such as:severe cardiac impairment (nyha grade 3 or 4 cardiomyopathy)/serum creatinine 2 x uln unless related to all /alt or ast 5 x uln unless related to all /pancreatitis history /other malignancy that all / severe infection, hiv positive, active hepatitis related to b or c virus infection / trisomy 21 / other serious conditions according to investigator's opinion
boolean
C3665472 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
allergy e.coli l-asparaginase
Item
known grade 4 allergic reaction to e.coli l-asparaginase (according nci-ctcae, version 3.0)
boolean
C0020517 (UMLS CUI [1,1])
C3255308 (UMLS CUI [1,2])
Transfusion Grade three rank
Item
history of grade 3 transfusional incident
boolean
C1879316 (UMLS CUI [1,1])
C0450094 (UMLS CUI [1,2])
Antierythrocyte Antibody
Item
presence of specific anti-erythrocyte antibodies preventing from getting a compatible erythrocyte concentrate for the patient
boolean
C0236506 (UMLS CUI [1])
hemolysis; Concomitant Therapy
Item
patient under concomitant treatment likely to cause hemolysis
boolean
C0019054 (UMLS CUI [1])
C1707479 (UMLS CUI [2])
yellow fever vaccination
Item
patient undergoing yellow fever vaccination
boolean
C0199823 (UMLS CUI [1])
phenytoin treatment
Item
patient under phenytoin treatment
boolean
C0747579 (UMLS CUI [1])
Study Subject Participation Status
Item
patient included in previous clinical study less than 6 weeks ago
boolean
C2348568 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial